SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a biotechnology company developing innovative therapeutics directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today will present research ...
Once brushed aside as a curiosity, extrachromosomal DNA (ecDNA) is now taking centrestage in the complex field of cancer biology. Scientists first discovered it as a small fragment of genetic material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback